Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Enrolling by invitation × Melanoma × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Completed 135 Terminated 65 Recruiting 65 Unknown 33 Active not recruiting 25 Withdrawn 22 Not yet recruiting 5 Suspended 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Glioma 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenoviridae Infections 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Prostatic Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Graft vs Host Disease 1 Glioblastoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Advanced Solid Tumors 1

Interventions

Ruthenium-106 1 Radiotherapy 1 Melphalan 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡